Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Julphar
Baxter
McKesson
Accenture
Citi
Express Scripts
Argus Health
Merck
Harvard Business School

Generated: October 23, 2017

DrugPatentWatch Database Preview

Entacapone - Generic Drug Details

« Back to Dashboard

What are the generic sources for entacapone and what is the scope of entacapone patent protection?

Entacapone
is the generic ingredient in two branded drugs marketed by Macleods Pharms Ltd, Aurobindo Pharma Ltd, Wockhardt Ltd, Sun Pharma Global, Ajanta Pharma Ltd, Mylan Pharms Inc, and Orion Pharma, and is included in seven NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Entacapone has forty-eight patent family members in thirty-seven countries.

There are nineteen drug master file entries for entacapone. Seventeen suppliers are listed for this compound.

Summary for Generic Name: entacapone

US Patents:1
Tradenames:2
Applicants:7
NDAs:7
Drug Master File Entries: see list19
Suppliers / Packagers: see list17
Bulk Api Vendors: see list44
Clinical Trials: see list40
Patent Applications: see list4,309
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:entacapone at DailyMed

Pharmacology for Ingredient: entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Wockhardt Ltd
ENTACAPONE
entacapone
TABLET;ORAL078941-001Aug 16, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
ENTACAPONE
entacapone
TABLET;ORAL205792-001Aug 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
ENTACAPONE
entacapone
TABLET;ORAL090690-001Jul 16, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ENTACAPONE
entacapone
TABLET;ORAL203437-001Jun 19, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ENTACAPONE
entacapone
TABLET;ORAL202394-001May 13, 2013DISCNNoNo► Subscribe► Subscribe► Subscribe
Macleods Pharms Ltd
ENTACAPONE
entacapone
TABLET;ORAL207210-001Jun 5, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: entacapone

Country Document Number Estimated Expiration
Malaysia124394► Subscribe
European Patent Office1112065► Subscribe
Georgia, Republic ofP20033062► Subscribe
Brazil9913681► Subscribe
Australia5748299► Subscribe
Norway20011278► Subscribe
South Africa200102084► Subscribe
Israel141681► Subscribe
Peru10602000► Subscribe
Estonia200100147► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Queensland Health
US Department of Justice
Daiichi Sankyo
Federal Trade Commission
Accenture
McKesson
Cerilliant
QuintilesIMS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot